Biblio Discovery — Demo Discovery Service

7 results for "Adam, Isa"

Showing 1–7 · 0.67 seconds · RSS

  1. Journal Article Full text

    Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda

    Kabugo, Joel; Namutebi, Joanita; Adam, Isa et al.

    PLoS One · 2023 · English · PubMed Central

    BACKGROUND: Proficiency testing (PT) has been hard to set up due to cost limitations and technical capacity. Conventional Xpert MTB/RIF PT programs use liquid and culture spots which require stringent storage and transportation conditions with cross-contamination chances prevalent. These setbacks…

  2. Journal Article Full text

    Impact of randomized blinded rechecking program on the performance of the AFB Microscopy Laboratory Network in Uganda: a decadal retrospective study

    Nsawotebba, Andrew; Ibanda, Ivan; Mujuni, Dennis et al.

    BMC Infect Dis · 2023 · English · PubMed Central

    BACKGROUND: Smear microscopy has remained the initial diagnostic test for presumptive tuberculosis (TB) patients in health facilities without the World Health Organization (WHO) recommended rapid diagnostic tools. In the Uganda TB laboratory network, the technique remains the only tool to monitor…

  3. Journal Article Full text

    First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda

    Kabahita, Jupiter Marina; Kabugo, Joel; Kakooza, Francis et al.

    Antimicrob Resist Infect Control · 2022 · English · PubMed Central

    BACKGROUND: Uganda remains one of the countries with the highest burden of TB/HIV. Drug-resistant TB remains a substantial challenge to TB control globally and requires new strategic effective control approaches. Drug resistance usually develops due to inadequate management of TB patients including…

  4. Journal Article Full text

    Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies

    Saei, Azad; Palafox, Marta; Benoukraf, Touati et al.

    J Exp Med · 2018 · English · PubMed Central

    RAF kinase inhibitors are clinically active in patients with BRAF (V600E) mutant melanoma. However, rarely do tumors regress completely, with the majority of responses being short-lived. This is partially mediated through the loss of negative feedback loops after MAPK inhibition and reactivation of…

  5. Journal Article Full text

    The development and implementation of a proficiency testing program for SARS-CoV-2 using dried tube specimens in resource-limited countries

    Lutaaya, Pius; Guido, Ocung; Ssentamu, Hasifah Nakato et al.

    BMC Infect Dis · 2024 · English · PubMed Central

    INTRODUCTION: When COVID-19 hit the world in 2019, an enhanced focus on diagnostic testing for SARS-CoV-2 was essential for a successful pandemic response. Testing laboratories stretched their capabilities for the new coronavirus by adopting different test methods. The necessity of having external…

  6. Journal Article Full text

    Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania

    Mutayoba, Beatrice Kemilembe; Michael Hoelscher; Heinrich, Norbert et al.

    BMC Genomics · 2022 · English · PubMed Central

    BACKGROUND: Mycobacterium tuberculosis presents several lineages each with distinct characteristics of evolutionary status, transmissibility, drug resistance, host interaction, latency, and vaccine efficacy. Whole genome sequencing (WGS) has emerged as a new diagnostic tool to reliably inform the…

  7. Journal Article Full text

    Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition

    Sundar, Raghav; Huang, Kie-Kyon; Kumar, Vikrant et al.

    Gut · 2021 · English · PubMed Central

    OBJECTIVES: Epigenomic alterations in cancer interact with the immune microenvironment to dictate tumour evolution and therapeutic response. We aimed to study the regulation of the tumour immune microenvironment through epigenetic alternate promoter use in gastric cancer and to expand our findings…